Not feeling any different on Mounjaro — what's actually happening

Why does the starter dose feel like it isn't doing anything?

The 2.5mg starting dose exists to reduce the chance of nausea and other gastrointestinal discomfort during the first month of treatment. It activates Mounjaro's dual GIP and GLP-1 receptors, but at a level your body is meant to adjust to rather than respond dramatically to. Think of it as your system's settling-in period rather than the treatment itself.

A common misconception worth letting go gently: that feeling side effects early means the medicine is working, and feeling nothing means it isn't. That's not how tirzepatide works. Some people experience noticeable nausea from the outset; others feel essentially nothing until they reach 5mg or higher. Both experiences are entirely consistent with the medicine doing its job. The full picture of how Mounjaro tends to feel varies considerably between individuals, and early tolerance of a low dose is not a sign the treatment will be ineffective.

Appetite suppression, which is the main mechanism behind weight loss on tirzepatide, often only becomes noticeable once the dose has been titrated upward. Some people describe a clear reduction in hunger at 5mg; for others it arrives at 7.5mg or beyond. The NHS tirzepatide medicines page reflects this: the dose escalation schedule is built into the medicine's design, not something to rush or skip.

What does 'working' actually look like at the start?

It's tempting to expect a noticeable moment, a point where you suddenly feel less hungry or the scales move sharply. In practice, the earliest signs are often quieter than that. You might finish a meal a little sooner. You might feel less compelled to snack in the evening. You might not notice any of this consciously and only see it later on in what you ate over a week.

Weight itself can lag behind appetite changes by two to four weeks, especially if fluid retention or digestive timing is affecting the number on your scales. The SURMOUNT-1 trial, which reported average weight reductions of around 20–21% at the highest dose over 72 weeks, involved participants who saw the most meaningful results in months three to twelve, not the first few weeks. For context on how results accumulate across the full treatment period, our page on losing weight slowly on Mounjaro covers what a realistic trajectory looks like.

If nothing at all has changed after two or three dose increases, it's worth a conversation with your prescriber. That's different from seeing no dramatic effect at 2.5mg, which is entirely expected.

Does the medicine need time to build up, or is it immediate?

Tirzepatide reaches steady-state concentrations in the body after roughly four to five weekly doses, meaning the medicine accumulates slightly over the first month. So even if the biological effect begins with the first injection, the pharmacological picture isn't fully established until the end of the first pen. This is another reason the 2.5mg phase can feel uneventful: the medicine is finding its level in your system at the same time as your body is finding its level with the medicine.

Some people also underestimate the role of lifestyle factors here. Tirzepatide works alongside a reduced-calorie diet and increased activity, the NICE appraisal of tirzepatide (TA1026) reflects this in how the medicine is licensed. If eating habits haven't shifted much at all yet, appetite changes driven by a low starting dose may not produce a visible effect on the scales even if the medicine is active.

If you've come across this medicine under a different brand or generic name, our page on the different names tirzepatide is known by can help clarify whether you're looking at the same treatment. Questions about what Mounjaro costs privately through a regulated service are worth weighing up alongside what realistic outcomes look like over a full course of treatment. The cost picture makes more sense in that longer frame. A prescriber can also clarify whether your current dose is where you'd expect to be at this stage of treatment.

When should you actually speak to someone about this?

If you're at 2.5mg and feeling nothing, the honest answer is: wait. That's the expected experience. If you're at 7.5mg or above and appetite hasn't shifted at all, weight has been completely flat for eight or more weeks, and nothing in your routine has changed, then raising it with your prescriber is the right step. It's not a failure of the medicine or of you, some people respond more fully at higher doses, and a clinical eye on your individual pattern is more useful than a general answer here.

At nume, a real clinician reviews every repeat prescription before it's approved. There's no automated process between your update and a prescriber's assessment. If you're unsure whether what you're experiencing is normal, our general FAQs cover common early-treatment questions, and the team is reachable seven days a week. You can also read more about Mounjaro as a treatment to get a fuller picture of what the medicine does across a full titration course. Check your eligibility for treatment by starting a free consultation, there's no obligation, and a prescriber will assess whether the treatment is appropriate for your situation.